Navigation Links
Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus
Date:11/9/2007

dy.

Key Findings to Date from the Phase 2 Study

In June 2006, HGS reported the 52-week results of the Phase 2 trial of LymphoStat-B in patients with SLE. The 52-week results demonstrated that LymphoStat-B significantly reduced disease activity versus placebo in patients with serologically active SLE across multiple clinical measures, exhibited clinically relevant biological activity, and appeared generally safe and well tolerated. Frequency and severity of adverse events were similar to placebo, with no increase at higher doses. Among the findings at Week 52 was a significantly improved response rate among serologically active patients, as defined by an improvement in SELENA SLEDAI score of 4 points or greater, no new BILAG A flare and no more than one new BILAG B flare, and no worsening in Physician's Global Assessment (46% for LymphoStat-B versus 29% for placebo, p<0.01). This combination of measures is the primary efficacy endpoint in the ongoing pivotal Phase 3 clinical trials.

The data presented today at ACR 2007 demonstrated that LymphoStat-B achieved sustained improvement or stabilization of SLE disease activity in serogically active patients through 2.5 years. LymphoStat-B also decreased the frequency of SLE disease flares in these patients over time. The overall incidence of adverse events and laboratory abnormalities remained stable or decreased from Week 52 to Week 128.

The evidence of sustained clinical effect in serologically active SLE patients from Week 52 to Week 128 includes:

-- An increase from 46% to 54% in the combined patient response rate

selected as the primary efficacy endpoint of the Phase 3 trials. Among

serologically active subjects who completed 128 weeks of treatment

(n=175), 63% responded based on this measure of clinical effect.

-- An increase from 49% to 58% in the proportion of patients who had

improvement in SLE disease activity, as measured by SELENA SLEDAI'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. Enrollment Begins on Human PK Study for Medidur(TM) FA
4. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
5. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Tianyin Pharmaceutical Co., Inc. (NYSE Amex: ... specializes in patented biopharmaceutical, modernized traditional Chinese medicine ... today updates the timeline for the GMP certification ... The Company is scheduled to submit the ... & Drug Administration,s (CFDA) review in the week ...
(Date:8/28/2014)...  Decision Resources Group finds that the market for colorectal ... by 2023 in the United States , ... Italy , Spain , ... Japan . The biosimilar erosion of Roche/Genentech/Chugai,s Avastin and ... the launch of Eli Lilly,s Cyramza, Taiho Pharmaceutical,s Lonsurf, Alchemia,s ...
(Date:8/28/2014)... Levi & Korsinsky announces that a class ... District Court for the District of Nevada ... Therapeutics Inc. ("Galectin" or the "Company") (NasdaqCM: GALT) securities ... For more information, click here: http://zlk.9nl.com/galectin-therapeutics-galt . ... Period the Company violated federal securities laws by issuing ...
Breaking Medicine Technology:TPI Submits Dataset for GMP Inspection at Qionglai Facility (QLF) 2The Colorectal Cancer Market Will Remain Steady at $7.7 Billion by 2023, With Biosimilar Erosion Of Key Agents Being Balanced Out By the Launch Of Premium-Priced Therapies 2SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT 2
... China, Dec. 27, 2011 /PRNewswire-Asia/ -- China Botanic ... ("China Botanic" or the "Company"), a developer, manufacturer ... Chinese Medicines ("TCM") in China, today announced that ... the 66th PHARMCHINA fair ("the Fair") recently held ...
... Reportlinker.com announces that a new ... its catalogue: Europe ... 2017- Glucose Monitoring and Insulin Delivery ... Europe Diabetes Care Devices ...
Cached Medicine Technology:China Botanic Exhibits All-Natural Anti-depressant Products at the 66th PHARMCHINA Fair 2China Botanic Exhibits All-Natural Anti-depressant Products at the 66th PHARMCHINA Fair 3Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 2Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 3Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 4Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 5Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 6Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 7Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 8Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 9Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 10Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 11Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 12
(Date:8/29/2014)... 29, 2014 According to The Madison-St. ... Pfizer Inc., Greenstone LLC and Pfizer R&D Cortex District ... defects as a result of using Zoloft during ... filed in St. Clair County Circuit Court (Case No. ... the defendant companies allegedly concealed the risks of serious ...
(Date:8/29/2014)... 29, 2014 Until now, databases have ... or unstructured data (document stores). SQL products have handled ... basically managed the wide assortment of unstructured data. It ... with Big Data is with a NoSQL Database. Unique ... aspects of all Big Data issues. Scientel ...
(Date:8/28/2014)... Career Step, an online provider of career-focused education ... to help students and career seekers explore the opportunities ... video details what medical coders and billers do, what ... education requirements for entering this field. , “Medical coding ... people are considering a career in healthcare,” said Jerolyn ...
(Date:8/28/2014)... When David Gergen, President of Pro Player ... was asked to publicly support Mr. Brnovich in his ... seat in the State of Arizona, Mr. Gergen could ... Hall of Fame wide receiver Roy Green in addition ... Green, Kennard and Walczak are members of Pro Player ...
(Date:8/28/2014)... emergency department with complaints of nausea, vomiting, anxiety ... business lunches, and at home every evening. Worried ... and had his last Scotch 24 hours before ... in emergency rooms across Canadaa patient suddenly stops ... Withdrawal is a potentially fatal condition that is ...
Breaking Medicine News(10 mins):Health News:The Law Office of Melinda J. Helbock A.P.C. Comments on Zoloft Birth Defect Lawsuit 2Health News:Scientel Announces Support for SQL Queries and Relational Tables Within Its Gensonix® NoSQL DB 2Health News:Scientel Announces Support for SQL Queries and Relational Tables Within Its Gensonix® NoSQL DB 3Health News:Scientel Announces Support for SQL Queries and Relational Tables Within Its Gensonix® NoSQL DB 4Health News:Career Step Releases New Video Designed to Help Students Explore the Medical Coding and Billing Field 2Health News:Pro Player Health Alliance Back in the Political Arena 2Health News:Pro Player Health Alliance Back in the Political Arena 3Health News:Real tremors, or drug-seeking patient? New app can tell 2Health News:Real tremors, or drug-seeking patient? New app can tell 3
... ... you up-to-date on embargoed studies and other news being presented at the ... 23-27 in Seattle. All briefs are embargoed until the date/time they are ... registration, or to arrange interviews with presenters, please contact ASPS Public Relations ...
... /PRNewswire-Asia-FirstCall / -- Winner Medical,Group Inc. (OTC Bulletin Board: WWIN; ... largest exporter by volume in the medical,dressing industry in China, ... 6, 2009. , The Company will ... under the new symbol "WWIN" when market opened on October ...
... 6 People with primary immunodeficiency diseases (PIDD) and ... one another and share their experiences through a new ... Foundation (IDF) announced today. Primary immunodeficiency ... by hereditary or genetic defects in the immune system. ...
... identifies competitive advantage for employers from effective health, ... Oct. 6 To help employers gauge benefits-program ... today the country,s largest single-source benchmarking database across ... The 2008 IBI Benchmarking database compares how employers, ...
... Institutes of Health announced today a second phase of ... for 19 research consortia. The Rare Diseases Clinical Research ... be awarded a total of just over $117 million ... the new funding will explore the natural history, epidemiology, ...
... led some organizations and communities to establish smoking bans ... effectiveness of such bans in protecting people from health ... a matter of continuing debate. Secondhand-Smoke Exposure and ... report from the Institute of Medicine, provides a comprehensive ...
Cached Medicine News:Health News:Plastic Surgery 2009 News Briefs -- Research To Be Presented on Saturday, October 24 2Health News:Plastic Surgery 2009 News Briefs -- Research To Be Presented on Saturday, October 24 3Health News:Plastic Surgery 2009 News Briefs -- Research To Be Presented on Saturday, October 24 4Health News:Plastic Surgery 2009 News Briefs -- Research To Be Presented on Saturday, October 24 5Health News:Winner Medical One for Two Reverse Stock Split Becomes Effective and Begins Trading Under New Symbol: WWIN 2Health News:Immune Deficiency Foundation Among the First Rare Disease Patient Organizations to Launch Major Social Networking Initiatives 2Health News:Immune Deficiency Foundation Among the First Rare Disease Patient Organizations to Launch Major Social Networking Initiatives 3Health News:Integrated Benefits Institute Announces Availability of 2008 IBI Benchmarking Industry Reports 2Health News:Integrated Benefits Institute Announces Availability of 2008 IBI Benchmarking Industry Reports 3Health News:NIH announces expansion of Rare Diseases Clinical Research Network 2Health News:NIH announces expansion of Rare Diseases Clinical Research Network 3Health News:NIH announces expansion of Rare Diseases Clinical Research Network 4Health News:NIH announces expansion of Rare Diseases Clinical Research Network 5Health News:NIH announces expansion of Rare Diseases Clinical Research Network 6Health News:NIH announces expansion of Rare Diseases Clinical Research Network 7Health News:NIH announces expansion of Rare Diseases Clinical Research Network 8
... Your patient will be more comfortable, ... tracheostomy tube stabilization more secure and to ... tying and untying of twill ties, consider ... adult and neonate/infant sizes, the narrow fastener ...
... for ease of use and patient comfort, ... edges for comfort and is available in ... a perfect fit. For hard to fit ... collar to your specifications. Don't just take ...
... in place. Soft strap features an adjustable ... compliant foam laminate with elastic adjustment increases ... while still providing a snug fit. Soft ... prevent sliding and patient irritation, and also ...
... and alternate care facilities with a ... which offer the finest in nursing ... the guidance of experienced nursing personnel, ... what is required for efficient and ...
Medicine Products: